Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80342
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Risperidone Risperdal® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Antipsychotic (Neuroleptic)
2 9-Hydroxyrisperidone Risperidone Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Antipsychotic (Neuroleptic)
3 Risperidone and 9-Hydroxyrisperidone - Total Total Active Moiety High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL Antipsychotic (Neuroleptic)

Specimen Type
Blood
Requested Volume
1 mL
Minimum Volume
0.4 mL
Special Handling
None
Specimen Container
NMS Labs has no experimental or literature-based data regarding the choice of specific specimen collection containers for this test.

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 14 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): 7 month(s)
1 Risperidone Risperdal® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Antipsychotic (Neuroleptic)
2 9-Hydroxyrisperidone Risperidone Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1 Antipsychotic (Neuroleptic)
3 Risperidone and 9-Hydroxyrisperidone - Total Total Active Moiety High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL Antipsychotic (Neuroleptic)

Interface Map

LOINC® Information